Heide Ford
Concepts (411)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Homeodomain Proteins | 31 | 2026 | 523 | 7.240 |
Why?
| | Protein Tyrosine Phosphatases | 24 | 2026 | 168 | 5.500 |
Why?
| | Breast Neoplasms | 27 | 2025 | 2321 | 3.520 |
Why?
| | Epithelial-Mesenchymal Transition | 13 | 2025 | 219 | 3.470 |
Why?
| | Gene Expression Regulation, Neoplastic | 29 | 2025 | 1489 | 3.100 |
Why?
| | Intracellular Signaling Peptides and Proteins | 17 | 2026 | 475 | 2.690 |
Why?
| | Nuclear Proteins | 17 | 2026 | 760 | 2.600 |
Why?
| | Triple Negative Breast Neoplasms | 6 | 2025 | 206 | 2.340 |
Why?
| | Cell Line, Tumor | 41 | 2026 | 3615 | 1.990 |
Why?
| | Transforming Growth Factor beta | 7 | 2012 | 484 | 1.940 |
Why?
| | Neoplasm Metastasis | 17 | 2025 | 682 | 1.930 |
Why?
| | Neoplasms | 17 | 2025 | 2812 | 1.900 |
Why?
| | Neoplastic Stem Cells | 10 | 2025 | 414 | 1.850 |
Why?
| | MicroRNAs | 6 | 2018 | 698 | 1.650 |
Why?
| | TNF-Related Apoptosis-Inducing Ligand | 6 | 2017 | 53 | 1.510 |
Why?
| | Vascular Endothelial Growth Factor C | 3 | 2020 | 16 | 1.470 |
Why?
| | Drug Resistance, Neoplasm | 10 | 2026 | 879 | 1.320 |
Why?
| | Cell Transformation, Neoplastic | 6 | 2015 | 341 | 1.300 |
Why?
| | Signal Transduction | 20 | 2025 | 5220 | 1.200 |
Why?
| | Muscle Development | 2 | 2022 | 115 | 1.080 |
Why?
| | DNA-Binding Proteins | 7 | 2025 | 1524 | 1.070 |
Why?
| | Sarcoma, Ewing | 2 | 2023 | 100 | 1.070 |
Why?
| | Up-Regulation | 9 | 2018 | 863 | 1.000 |
Why?
| | Protein Phosphatase 2 | 3 | 2025 | 42 | 0.970 |
Why?
| | Cell Plasticity | 2 | 2025 | 39 | 0.910 |
Why?
| | Zebrafish Proteins | 2 | 2022 | 300 | 0.910 |
Why?
| | Transcription Factors | 7 | 2022 | 1754 | 0.900 |
Why?
| | Rhabdomyosarcoma | 2 | 2024 | 63 | 0.890 |
Why?
| | Mammary Glands, Human | 4 | 2010 | 67 | 0.890 |
Why?
| | Chemokine CCL2 | 1 | 2025 | 116 | 0.880 |
Why?
| | Animals | 52 | 2026 | 38080 | 0.860 |
Why?
| | Oncogene Proteins, Fusion | 4 | 2024 | 214 | 0.840 |
Why?
| | Disease Progression | 5 | 2025 | 2862 | 0.800 |
Why?
| | Proto-Oncogene Proteins c-myc | 3 | 2025 | 168 | 0.730 |
Why?
| | Killer Cells, Natural | 1 | 2025 | 475 | 0.700 |
Why?
| | Cerebellar Neoplasms | 1 | 2023 | 179 | 0.700 |
Why?
| | Medulloblastoma | 1 | 2023 | 218 | 0.680 |
Why?
| | NF-kappa B | 1 | 2025 | 685 | 0.680 |
Why?
| | Receptors, TNF-Related Apoptosis-Inducing Ligand | 3 | 2017 | 30 | 0.680 |
Why?
| | Neuropilin-2 | 1 | 2020 | 3 | 0.680 |
Why?
| | Antineoplastic Agents | 9 | 2024 | 2195 | 0.670 |
Why?
| | Mammary Neoplasms, Experimental | 5 | 2012 | 68 | 0.660 |
Why?
| | Mice | 31 | 2026 | 18423 | 0.640 |
Why?
| | Cell Transdifferentiation | 2 | 2010 | 31 | 0.640 |
Why?
| | Humans | 78 | 2026 | 143878 | 0.630 |
Why?
| | Cadherins | 2 | 2014 | 203 | 0.610 |
Why?
| | Mice, SCID | 9 | 2019 | 373 | 0.610 |
Why?
| | Breast | 1 | 2020 | 158 | 0.600 |
Why?
| | Cell Differentiation | 10 | 2026 | 2023 | 0.600 |
Why?
| | Pluripotent Stem Cells | 1 | 2020 | 81 | 0.600 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 2 | 2016 | 65 | 0.580 |
Why?
| | Proto-Oncogene Protein c-fli-1 | 2 | 2023 | 26 | 0.570 |
Why?
| | RNA-Binding Protein EWS | 2 | 2023 | 28 | 0.570 |
Why?
| | Transcriptional Activation | 3 | 2018 | 380 | 0.560 |
Why?
| | Nedd4 Ubiquitin Protein Ligases | 1 | 2018 | 15 | 0.560 |
Why?
| | SOXB1 Transcription Factors | 1 | 2019 | 66 | 0.560 |
Why?
| | Neoplasm Proteins | 3 | 2018 | 443 | 0.560 |
Why?
| | Epithelial Cells | 5 | 2012 | 1129 | 0.550 |
Why?
| | Receptor, Notch1 | 1 | 2018 | 65 | 0.540 |
Why?
| | Zinc Finger Protein GLI1 | 1 | 2017 | 26 | 0.530 |
Why?
| | Mice, Inbred NOD | 6 | 2019 | 611 | 0.530 |
Why?
| | Anion Transport Proteins | 1 | 2017 | 8 | 0.510 |
Why?
| | Cell Proliferation | 12 | 2024 | 2543 | 0.510 |
Why?
| | Paracrine Communication | 1 | 2017 | 67 | 0.510 |
Why?
| | Female | 37 | 2025 | 77456 | 0.490 |
Why?
| | Down-Regulation | 2 | 2015 | 644 | 0.490 |
Why?
| | Genetic Heterogeneity | 1 | 2016 | 64 | 0.480 |
Why?
| | B7-H1 Antigen | 1 | 2018 | 234 | 0.470 |
Why?
| | Ribosomal Proteins | 1 | 2015 | 93 | 0.460 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2019 | 1104 | 0.450 |
Why?
| | Twist-Related Protein 1 | 1 | 2015 | 9 | 0.450 |
Why?
| | Gene Regulatory Networks | 3 | 2026 | 319 | 0.450 |
Why?
| | Mammary Glands, Animal | 3 | 2010 | 129 | 0.440 |
Why?
| | Nerve Tissue Proteins | 1 | 2019 | 607 | 0.440 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2016 | 541 | 0.440 |
Why?
| | Cell Cycle | 4 | 2013 | 648 | 0.430 |
Why?
| | Mesoderm | 3 | 2009 | 147 | 0.430 |
Why?
| | Epithelium | 3 | 2009 | 314 | 0.420 |
Why?
| | Receptors, Transforming Growth Factor beta | 2 | 2012 | 55 | 0.420 |
Why?
| | Tumor Microenvironment | 3 | 2025 | 733 | 0.420 |
Why?
| | Retina | 2 | 2026 | 324 | 0.420 |
Why?
| | Neoplasm Transplantation | 6 | 2014 | 253 | 0.410 |
Why?
| | Protein Binding | 9 | 2025 | 2270 | 0.410 |
Why?
| | MCF-7 Cells | 4 | 2020 | 130 | 0.400 |
Why?
| | Branchio-Oto-Renal Syndrome | 2 | 2013 | 7 | 0.400 |
Why?
| | Interferons | 2 | 2025 | 196 | 0.400 |
Why?
| | Lung Neoplasms | 4 | 2019 | 2583 | 0.380 |
Why?
| | Molecular Targeted Therapy | 2 | 2015 | 432 | 0.380 |
Why?
| | Small Molecule Libraries | 3 | 2025 | 107 | 0.380 |
Why?
| | Transcription, Genetic | 3 | 2014 | 1511 | 0.380 |
Why?
| | Superoxide Dismutase | 1 | 2014 | 346 | 0.370 |
Why?
| | Gene Expression Regulation, Developmental | 5 | 2017 | 896 | 0.370 |
Why?
| | Lymphangiogenesis | 1 | 2012 | 26 | 0.370 |
Why?
| | Genes, Tumor Suppressor | 1 | 2012 | 90 | 0.360 |
Why?
| | Smad7 Protein | 1 | 2012 | 20 | 0.360 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 177 | 0.350 |
Why?
| | Mice, Nude | 7 | 2017 | 710 | 0.340 |
Why?
| | Genes, Homeobox | 3 | 2022 | 51 | 0.320 |
Why?
| | Apoptosis | 4 | 2019 | 2519 | 0.310 |
Why?
| | Bone Neoplasms | 1 | 2012 | 251 | 0.310 |
Why?
| | Cyclin A | 3 | 2009 | 24 | 0.300 |
Why?
| | Mice, Inbred BALB C | 4 | 2019 | 1272 | 0.300 |
Why?
| | Embryonic Development | 1 | 2010 | 123 | 0.300 |
Why?
| | Enzyme Inhibitors | 7 | 2024 | 840 | 0.300 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2025 | 942 | 0.280 |
Why?
| | Prognosis | 6 | 2019 | 4164 | 0.280 |
Why?
| | Cell Movement | 5 | 2020 | 973 | 0.270 |
Why?
| | Tyrosine | 3 | 2024 | 229 | 0.270 |
Why?
| | Genomic Instability | 1 | 2008 | 61 | 0.260 |
Why?
| | Cell Hypoxia | 2 | 2025 | 241 | 0.260 |
Why?
| | Ovarian Neoplasms | 3 | 2012 | 587 | 0.240 |
Why?
| | Synthetic Lethal Mutations | 1 | 2026 | 4 | 0.240 |
Why?
| | Heterografts | 3 | 2017 | 138 | 0.240 |
Why?
| | Eukaryotic Initiation Factor-3 | 1 | 2025 | 10 | 0.240 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2012 | 1832 | 0.230 |
Why?
| | Central Nervous System Neoplasms | 2 | 2026 | 174 | 0.230 |
Why?
| | Gene Knockdown Techniques | 3 | 2016 | 336 | 0.230 |
Why?
| | STAT1 Transcription Factor | 1 | 2025 | 71 | 0.220 |
Why?
| | Cell Survival | 3 | 2026 | 1136 | 0.220 |
Why?
| | Proto-Oncogene Protein c-ets-1 | 1 | 2024 | 25 | 0.220 |
Why?
| | Gene Amplification | 1 | 2005 | 111 | 0.220 |
Why?
| | Myeloid Cells | 1 | 2026 | 148 | 0.220 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2024 | 76 | 0.220 |
Why?
| | Neoplasm Invasiveness | 3 | 2024 | 521 | 0.210 |
Why?
| | Myosins | 1 | 2024 | 138 | 0.210 |
Why?
| | Rosaniline Dyes | 1 | 2024 | 15 | 0.210 |
Why?
| | Protein Biosynthesis | 2 | 2025 | 453 | 0.210 |
Why?
| | Zebrafish | 2 | 2022 | 513 | 0.210 |
Why?
| | Kaplan-Meier Estimate | 2 | 2020 | 923 | 0.200 |
Why?
| | Peptides | 3 | 2025 | 981 | 0.200 |
Why?
| | Protein Stability | 2 | 2018 | 175 | 0.200 |
Why?
| | Eye Proteins | 1 | 2024 | 93 | 0.200 |
Why?
| | Drug Design | 1 | 2024 | 173 | 0.200 |
Why?
| | Gene Expression Profiling | 4 | 2012 | 1794 | 0.190 |
Why?
| | Integrins | 1 | 2023 | 94 | 0.190 |
Why?
| | Mitochondrial Proteins | 1 | 2024 | 262 | 0.190 |
Why?
| | Proto-Oncogene Proteins | 1 | 2026 | 626 | 0.190 |
Why?
| | Models, Biological | 4 | 2017 | 1831 | 0.180 |
Why?
| | Myogenin | 1 | 2022 | 15 | 0.180 |
Why?
| | Immunohistochemistry | 3 | 2018 | 1737 | 0.180 |
Why?
| | Rhabdomyosarcoma, Embryonal | 1 | 2022 | 16 | 0.180 |
Why?
| | MyoD Protein | 1 | 2022 | 32 | 0.180 |
Why?
| | Glioblastoma | 2 | 2026 | 351 | 0.180 |
Why?
| | HEK293 Cells | 3 | 2024 | 747 | 0.180 |
Why?
| | Cell Cycle Proteins | 1 | 2026 | 652 | 0.180 |
Why?
| | Transplantation, Heterologous | 4 | 2012 | 197 | 0.180 |
Why?
| | Tumor Cells, Cultured | 4 | 2019 | 974 | 0.170 |
Why?
| | Brain Neoplasms | 3 | 2024 | 1306 | 0.170 |
Why?
| | Chromatin | 1 | 2024 | 554 | 0.160 |
Why?
| | Cell Dedifferentiation | 2 | 2010 | 31 | 0.160 |
Why?
| | Trans-Activators | 3 | 2026 | 402 | 0.160 |
Why?
| | BRCA1 Protein | 1 | 2020 | 79 | 0.160 |
Why?
| | Hedgehog Proteins | 1 | 2020 | 200 | 0.150 |
Why?
| | Nanog Homeobox Protein | 1 | 2019 | 14 | 0.150 |
Why?
| | Oxygen | 1 | 2024 | 998 | 0.150 |
Why?
| | Prostatic Neoplasms | 2 | 2024 | 1058 | 0.150 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2026 | 662 | 0.150 |
Why?
| | Cyclin A1 | 3 | 2009 | 5 | 0.140 |
Why?
| | Phosphorylation | 3 | 2024 | 1782 | 0.140 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 994 | 0.140 |
Why?
| | Antigens, CD | 2 | 2014 | 550 | 0.140 |
Why?
| | Mutation | 1 | 2009 | 4061 | 0.140 |
Why?
| | Cell Growth Processes | 2 | 2008 | 53 | 0.130 |
Why?
| | RNA, Small Interfering | 2 | 2017 | 637 | 0.130 |
Why?
| | Blotting, Western | 3 | 2011 | 1223 | 0.130 |
Why?
| | Veratrum Alkaloids | 1 | 2017 | 20 | 0.130 |
Why?
| | Maxilla | 1 | 2017 | 36 | 0.130 |
Why?
| | DNA Damage | 3 | 2026 | 446 | 0.130 |
Why?
| | Basigin | 1 | 2017 | 24 | 0.130 |
Why?
| | RNA, Messenger | 3 | 2018 | 2854 | 0.130 |
Why?
| | Proteolysis | 2 | 2017 | 175 | 0.130 |
Why?
| | Carbolines | 1 | 1996 | 35 | 0.120 |
Why?
| | Oxidoreductases Acting on CH-CH Group Donors | 1 | 1996 | 27 | 0.120 |
Why?
| | Promoter Regions, Genetic | 3 | 2010 | 1263 | 0.120 |
Why?
| | Protein Structure, Tertiary | 2 | 2009 | 863 | 0.120 |
Why?
| | Cellular Reprogramming | 1 | 2017 | 103 | 0.120 |
Why?
| | Clone Cells | 1 | 2016 | 270 | 0.120 |
Why?
| | Multigene Family | 2 | 2008 | 205 | 0.120 |
Why?
| | Biphenyl Compounds | 1 | 1996 | 70 | 0.120 |
Why?
| | Oxidoreductases | 1 | 1996 | 95 | 0.120 |
Why?
| | Allosteric Regulation | 3 | 2024 | 91 | 0.120 |
Why?
| | Membrane Transport Proteins | 1 | 2017 | 156 | 0.120 |
Why?
| | Endothelin-1 | 1 | 2017 | 177 | 0.120 |
Why?
| | Cytidine | 2 | 1993 | 9 | 0.110 |
Why?
| | Epigenesis, Genetic | 2 | 2024 | 686 | 0.110 |
Why?
| | Receptors, Estrogen | 1 | 2018 | 425 | 0.110 |
Why?
| | Tumor Burden | 2 | 2017 | 319 | 0.110 |
Why?
| | Zinc Finger E-box Binding Homeobox 2 | 1 | 2014 | 6 | 0.110 |
Why?
| | Structure-Activity Relationship | 3 | 2024 | 577 | 0.110 |
Why?
| | Idiopathic Pulmonary Fibrosis | 1 | 2022 | 676 | 0.110 |
Why?
| | Claudins | 1 | 2014 | 24 | 0.110 |
Why?
| | Cell Nucleus | 2 | 2009 | 614 | 0.110 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2015 | 132 | 0.110 |
Why?
| | Mass Spectrometry | 1 | 2018 | 741 | 0.110 |
Why?
| | Gene Expression | 3 | 2009 | 1505 | 0.110 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2015 | 92 | 0.110 |
Why?
| | Genes, MHC Class I | 2 | 2005 | 36 | 0.100 |
Why?
| | Autophagy | 1 | 2016 | 287 | 0.100 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2014 | 100 | 0.100 |
Why?
| | Survival Rate | 1 | 2019 | 2008 | 0.100 |
Why?
| | RNA Interference | 2 | 2017 | 474 | 0.100 |
Why?
| | Gene Expression Regulation | 1 | 2023 | 2621 | 0.100 |
Why?
| | Transfection | 3 | 2017 | 950 | 0.100 |
Why?
| | Biomedical Research | 1 | 2020 | 699 | 0.100 |
Why?
| | Pyrimidines | 1 | 2017 | 524 | 0.100 |
Why?
| | G1 Phase | 1 | 2013 | 86 | 0.100 |
Why?
| | Child | 2 | 2023 | 22784 | 0.100 |
Why?
| | Amino Acid Sequence | 6 | 2014 | 2167 | 0.100 |
Why?
| | Pyridines | 1 | 2017 | 595 | 0.100 |
Why?
| | Disease-Free Survival | 1 | 2014 | 722 | 0.100 |
Why?
| | Cluster Analysis | 2 | 2012 | 526 | 0.100 |
Why?
| | Cyclin-Dependent Kinase 6 | 1 | 2013 | 73 | 0.090 |
Why?
| | Antibodies, Neoplasm | 1 | 2012 | 33 | 0.090 |
Why?
| | Neuroglia | 1 | 2013 | 173 | 0.090 |
Why?
| | Etoposide | 1 | 2012 | 165 | 0.090 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2012 | 763 | 0.090 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2018 | 928 | 0.090 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1286 | 0.090 |
Why?
| | Reactive Oxygen Species | 1 | 2014 | 643 | 0.090 |
Why?
| | Proteasome Endopeptidase Complex | 2 | 2017 | 160 | 0.090 |
Why?
| | Tissue Array Analysis | 1 | 2011 | 51 | 0.090 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2024 | 2057 | 0.090 |
Why?
| | Metabolic Networks and Pathways | 1 | 2012 | 186 | 0.080 |
Why?
| | Repressor Proteins | 1 | 2014 | 438 | 0.080 |
Why?
| | Proteasome Inhibitors | 1 | 2011 | 42 | 0.080 |
Why?
| | Cell Death | 2 | 2021 | 394 | 0.080 |
Why?
| | Lymphatic Metastasis | 1 | 2012 | 328 | 0.080 |
Why?
| | Antioxidants | 1 | 2014 | 594 | 0.080 |
Why?
| | Energy Metabolism | 1 | 2017 | 942 | 0.080 |
Why?
| | Antigens, Differentiation | 1 | 2010 | 78 | 0.080 |
Why?
| | Protein Domains | 2 | 2024 | 312 | 0.080 |
Why?
| | DNA Repair | 2 | 2026 | 251 | 0.080 |
Why?
| | Doxorubicin | 1 | 2012 | 383 | 0.080 |
Why?
| | Metaplasia | 1 | 2009 | 58 | 0.080 |
Why?
| | Smad3 Protein | 1 | 2009 | 44 | 0.080 |
Why?
| | Salivary Proteins and Peptides | 1 | 2009 | 15 | 0.070 |
Why?
| | Follow-Up Studies | 1 | 2019 | 5319 | 0.070 |
Why?
| | Lymphoma | 1 | 2011 | 229 | 0.070 |
Why?
| | Submandibular Gland | 1 | 2009 | 20 | 0.070 |
Why?
| | Mutant Proteins | 1 | 2009 | 104 | 0.070 |
Why?
| | Lymphocytes | 1 | 1991 | 398 | 0.070 |
Why?
| | Glioma | 1 | 2013 | 429 | 0.070 |
Why?
| | Lactation | 1 | 2010 | 193 | 0.070 |
Why?
| | Pancreatic Neoplasms | 1 | 2017 | 932 | 0.070 |
Why?
| | Protein Structure, Secondary | 1 | 2009 | 368 | 0.070 |
Why?
| | Amino Acid Substitution | 1 | 2009 | 311 | 0.070 |
Why?
| | Clinical Trials as Topic | 2 | 2012 | 1044 | 0.070 |
Why?
| | Eye Neoplasms | 1 | 2008 | 29 | 0.070 |
Why?
| | NIH 3T3 Cells | 1 | 2008 | 150 | 0.070 |
Why?
| | Cell Line | 3 | 2014 | 2899 | 0.070 |
Why?
| | Oxidative Stress | 1 | 2014 | 1376 | 0.070 |
Why?
| | Protein Transport | 1 | 2009 | 447 | 0.070 |
Why?
| | Ubiquitin | 1 | 2006 | 74 | 0.060 |
Why?
| | Myeloid Ecotropic Viral Integration Site 1 Protein | 1 | 2026 | 11 | 0.060 |
Why?
| | Amino Acid Motifs | 1 | 2006 | 226 | 0.060 |
Why?
| | DNA | 2 | 2009 | 1457 | 0.060 |
Why?
| | Gene Expression Regulation, Leukemic | 1 | 2026 | 57 | 0.060 |
Why?
| | Models, Molecular | 4 | 2019 | 1624 | 0.060 |
Why?
| | Disease Models, Animal | 2 | 2012 | 4544 | 0.060 |
Why?
| | Crystallography, X-Ray | 2 | 2019 | 488 | 0.060 |
Why?
| | Chromosomes, Human, Pair 14 | 1 | 2005 | 22 | 0.060 |
Why?
| | Antigens, CD1 | 1 | 2005 | 60 | 0.060 |
Why?
| | Ovary | 1 | 2007 | 229 | 0.060 |
Why?
| | Chickens | 1 | 2005 | 190 | 0.060 |
Why?
| | PAX3 Transcription Factor | 1 | 2024 | 17 | 0.060 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2025 | 124 | 0.060 |
Why?
| | Molecular Structure | 2 | 2024 | 504 | 0.050 |
Why?
| | Paired Box Transcription Factors | 1 | 2024 | 43 | 0.050 |
Why?
| | Precipitin Tests | 1 | 2004 | 97 | 0.050 |
Why?
| | Cryoelectron Microscopy | 1 | 2025 | 208 | 0.050 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2024 | 64 | 0.050 |
Why?
| | Mice, Transgenic | 1 | 2009 | 2194 | 0.050 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2024 | 197 | 0.050 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2025 | 296 | 0.050 |
Why?
| | Phylogeny | 2 | 2005 | 1008 | 0.050 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2003 | 31 | 0.050 |
Why?
| | Dogfish | 1 | 2003 | 4 | 0.050 |
Why?
| | Cyclin D1 | 1 | 2003 | 74 | 0.050 |
Why?
| | Cell Lineage | 1 | 2025 | 370 | 0.050 |
Why?
| | Molecular Sequence Data | 5 | 2014 | 2944 | 0.050 |
Why?
| | DNA, Complementary | 1 | 2003 | 277 | 0.050 |
Why?
| | Sequence Analysis, RNA | 1 | 2025 | 447 | 0.050 |
Why?
| | Fibroblasts | 1 | 2008 | 1048 | 0.050 |
Why?
| | Cell Division | 1 | 2004 | 806 | 0.050 |
Why?
| | Neovascularization, Pathologic | 1 | 2004 | 295 | 0.050 |
Why?
| | Mice, Inbred C57BL | 2 | 2010 | 6055 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2025 | 355 | 0.040 |
Why?
| | Evolution, Molecular | 1 | 2005 | 507 | 0.040 |
Why?
| | Kinetics | 2 | 2012 | 1628 | 0.040 |
Why?
| | Developmental Biology | 1 | 2020 | 23 | 0.040 |
Why?
| | Neural Stem Cells | 1 | 2021 | 164 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 545 | 0.040 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2014 | 398 | 0.040 |
Why?
| | Terminology as Topic | 1 | 2020 | 251 | 0.030 |
Why?
| | Consensus | 1 | 2020 | 542 | 0.030 |
Why?
| | Sp7 Transcription Factor | 1 | 2017 | 7 | 0.030 |
Why?
| | Zygoma | 1 | 2017 | 7 | 0.030 |
Why?
| | Serrate-Jagged Proteins | 1 | 2017 | 27 | 0.030 |
Why?
| | Branchial Region | 1 | 2017 | 38 | 0.030 |
Why?
| | Plasma Membrane Calcium-Transporting ATPases | 1 | 2017 | 10 | 0.030 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2017 | 23 | 0.030 |
Why?
| | Receptor, Endothelin A | 1 | 2017 | 63 | 0.030 |
Why?
| | Male | 6 | 2024 | 71702 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2012 | 11390 | 0.030 |
Why?
| | Quinaldines | 1 | 1996 | 1 | 0.030 |
Why?
| | Orotic Acid | 1 | 1996 | 2 | 0.030 |
Why?
| | Pregnancy | 1 | 2010 | 7169 | 0.030 |
Why?
| | Craniofacial Abnormalities | 1 | 2017 | 75 | 0.030 |
Why?
| | Autophagy-Related Proteins | 1 | 2016 | 47 | 0.030 |
Why?
| | DNA Primers | 3 | 2005 | 518 | 0.030 |
Why?
| | Diphtheria Toxin | 1 | 2016 | 65 | 0.030 |
Why?
| | Receptors, Notch | 1 | 2017 | 91 | 0.030 |
Why?
| | Ribonucleotides | 1 | 1996 | 26 | 0.030 |
Why?
| | Body Patterning | 1 | 2017 | 137 | 0.030 |
Why?
| | Integrases | 1 | 2017 | 123 | 0.030 |
Why?
| | Embryo, Mammalian | 1 | 2017 | 237 | 0.030 |
Why?
| | Phosphotyrosine | 1 | 1996 | 40 | 0.030 |
Why?
| | Neural Crest | 1 | 2017 | 123 | 0.030 |
Why?
| | Epidermal Growth Factor | 1 | 2016 | 174 | 0.030 |
Why?
| | Aspartic Acid | 1 | 1996 | 82 | 0.030 |
Why?
| | Sodium Bicarbonate | 1 | 1996 | 46 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2017 | 273 | 0.030 |
Why?
| | Statistics, Nonparametric | 2 | 2009 | 434 | 0.030 |
Why?
| | Cytidine Triphosphate | 2 | 1993 | 18 | 0.030 |
Why?
| | Cell Adhesion | 1 | 2017 | 456 | 0.030 |
Why?
| | Green Fluorescent Proteins | 1 | 2016 | 404 | 0.030 |
Why?
| | Calcium Signaling | 1 | 2017 | 248 | 0.030 |
Why?
| | Adult | 3 | 2015 | 40116 | 0.030 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2014 | 85 | 0.030 |
Why?
| | Carbon-Nitrogen Ligases | 1 | 1993 | 5 | 0.030 |
Why?
| | Leukemia L1210 | 1 | 1993 | 7 | 0.030 |
Why?
| | Calorimetry | 1 | 2014 | 71 | 0.030 |
Why?
| | Leukemia | 1 | 1996 | 245 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 2016 | 678 | 0.030 |
Why?
| | Molecular Docking Simulation | 1 | 2014 | 117 | 0.030 |
Why?
| | Colonic Neoplasms | 1 | 1996 | 260 | 0.030 |
Why?
| | Zinc Finger E-box-Binding Homeobox 1 | 1 | 2013 | 24 | 0.030 |
Why?
| | Magnesium | 1 | 2014 | 156 | 0.030 |
Why?
| | Amino Acids | 1 | 2017 | 511 | 0.020 |
Why?
| | Phenylhydrazines | 1 | 2012 | 4 | 0.020 |
Why?
| | Miniaturization | 1 | 2012 | 22 | 0.020 |
Why?
| | Protein Phosphatase 2C | 1 | 2012 | 16 | 0.020 |
Why?
| | Fluoresceins | 1 | 2012 | 47 | 0.020 |
Why?
| | Enzyme Assays | 1 | 2012 | 25 | 0.020 |
Why?
| | Time Factors | 2 | 2017 | 7042 | 0.020 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2012 | 65 | 0.020 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2012 | 44 | 0.020 |
Why?
| | Spleen | 2 | 2005 | 517 | 0.020 |
Why?
| | Spectrometry, Fluorescence | 1 | 2012 | 165 | 0.020 |
Why?
| | Kidney Neoplasms | 1 | 1996 | 407 | 0.020 |
Why?
| | Antibody Specificity | 1 | 2012 | 185 | 0.020 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2014 | 348 | 0.020 |
Why?
| | DNA Fragmentation | 1 | 2011 | 40 | 0.020 |
Why?
| | Sequence Analysis, DNA | 2 | 2005 | 823 | 0.020 |
Why?
| | Fas Ligand Protein | 1 | 2011 | 60 | 0.020 |
Why?
| | Mutation, Missense | 1 | 2013 | 346 | 0.020 |
Why?
| | Software | 1 | 1996 | 690 | 0.020 |
Why?
| | High-Throughput Screening Assays | 1 | 2012 | 163 | 0.020 |
Why?
| | Drug Synergism | 1 | 2011 | 370 | 0.020 |
Why?
| | Mitochondria | 1 | 1996 | 988 | 0.020 |
Why?
| | Brain | 1 | 2021 | 2899 | 0.020 |
Why?
| | HIV-1 | 1 | 1995 | 893 | 0.020 |
Why?
| | Melanoma | 1 | 1996 | 808 | 0.020 |
Why?
| | Azacitidine | 1 | 1990 | 149 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2009 | 330 | 0.020 |
Why?
| | RNA | 2 | 1993 | 934 | 0.020 |
Why?
| | Organ Size | 1 | 2009 | 481 | 0.020 |
Why?
| | Base Sequence | 2 | 2005 | 2200 | 0.020 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 1996 | 1135 | 0.020 |
Why?
| | Bursa of Fabricius | 1 | 2005 | 3 | 0.010 |
Why?
| | Blotting, Southern | 1 | 2005 | 83 | 0.010 |
Why?
| | Sequence Homology | 1 | 2005 | 44 | 0.010 |
Why?
| | Blotting, Northern | 1 | 2005 | 201 | 0.010 |
Why?
| | Conserved Sequence | 1 | 2005 | 243 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2005 | 367 | 0.010 |
Why?
| | Chromosome Mapping | 1 | 2005 | 517 | 0.010 |
Why?
| | Databases, Genetic | 1 | 2003 | 248 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2003 | 538 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2009 | 3112 | 0.010 |
Why?
| | HIV Infections | 1 | 1995 | 3018 | 0.010 |
Why?
| | Biological Evolution | 1 | 2003 | 493 | 0.010 |
Why?
| | Genetic Variation | 1 | 2003 | 1010 | 0.010 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2005 | 2181 | 0.010 |
Why?
| | Fluorine | 1 | 1996 | 17 | 0.010 |
Why?
| | Chemistry, Physical | 1 | 1996 | 37 | 0.010 |
Why?
| | Chemical Phenomena | 1 | 1996 | 80 | 0.010 |
Why?
| | src Homology Domains | 1 | 1996 | 36 | 0.010 |
Why?
| | Ions | 1 | 1996 | 67 | 0.010 |
Why?
| | Cricetinae | 1 | 1996 | 301 | 0.010 |
Why?
| | Dideoxyadenosine | 1 | 1995 | 3 | 0.010 |
Why?
| | Genes, env | 1 | 1995 | 5 | 0.010 |
Why?
| | Proviruses | 1 | 1995 | 16 | 0.010 |
Why?
| | Lymphocyte Transfusion | 1 | 1995 | 20 | 0.010 |
Why?
| | Lymphocyte Count | 1 | 1995 | 167 | 0.010 |
Why?
| | Viremia | 1 | 1995 | 156 | 0.010 |
Why?
| | Deamination | 1 | 1993 | 6 | 0.010 |
Why?
| | Ligases | 1 | 1993 | 36 | 0.010 |
Why?
| | Middle Aged | 2 | 2013 | 35429 | 0.010 |
Why?
| | Drug Resistance | 1 | 1993 | 153 | 0.010 |
Why?
| | DNA, Viral | 1 | 1995 | 367 | 0.010 |
Why?
| | Immunotherapy, Adoptive | 1 | 1995 | 380 | 0.010 |
Why?
| | Drug Evaluation | 1 | 1990 | 79 | 0.000 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 1995 | 1228 | 0.000 |
Why?
| | Leukopenia | 1 | 1990 | 32 | 0.000 |
Why?
| | Neutropenia | 1 | 1990 | 152 | 0.000 |
Why?
| | Antiviral Agents | 1 | 1995 | 763 | 0.000 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 1995 | 1130 | 0.000 |
Why?
| | Antibodies, Monoclonal | 1 | 1995 | 1477 | 0.000 |
Why?
| | Thrombocytopenia | 1 | 1990 | 209 | 0.000 |
Why?
| | Drug Administration Schedule | 1 | 1990 | 774 | 0.000 |
Why?
| | Aged | 1 | 1990 | 25377 | 0.000 |
Why?
|
|
Ford's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|